Day One Biopharmaceuticals News

Analysts Are Bullish on These Healthcare Stocks: OptimizeRx (OPRX), Day One Biopharmaceuticals (DAWN)

TipRanksApr 16 09:00 ET

Buy Rating on Day One Biopharmaceuticals Ahead of Tovorafenib PDUFA Date and Potential for Market Disruption

TipRanksApr 9 16:05 ET

Day One Biopharmaceutical Analyst Ratings

BenzingaMar 26 07:58 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), BioMarin Pharmaceutical (BMRN) and Argenx Se (ARGX)

TipRanksMar 26 07:10 ET

Analysts Are Bullish on Top Healthcare Stocks: Day One Biopharmaceuticals (DAWN), Crinetics Pharmaceuticals (CRNX)

TipRanksFeb 29 08:10 ET

Piper Sandler Sticks to Its Buy Rating for Day One Biopharmaceuticals (DAWN)

TipRanksFeb 28 07:31 ET

Buy Rating Reaffirmed for Day One Biopharmaceuticals Amid Tovorafenib's Promising Prospects and Financial Stability

TipRanksFeb 27 16:25 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)

TipRanksFeb 27 09:10 ET

Day One Biopharmaceuticals (DAWN) Receives a Hold From Oppenheimer

TipRanksFeb 27 07:49 ET

Day One Biopharmaceutical Analyst Ratings

BenzingaFeb 27 07:35 ET

Buy Rating Affirmed for Day One Biopharmaceuticals Amid Strong Pre-Launch Strategy and Solid Financials

TipRanksFeb 27 05:59 ET

Analysts Offer Insights on Healthcare Companies: FibroGen (FGEN), Karyopharm Therapeutics (KPTI) and Day One Biopharmaceuticals (DAWN)

TipRanksFeb 26 22:30 ET

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Day One Biopharmaceuticals (DAWN) and Masimo (MASI)

TipRanksNov 29, 2023 06:40 ET

Oppenheimer Remains a Hold on Day One Biopharmaceuticals (DAWN)

TipRanksNov 7, 2023 08:16 ET

Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Guardant Health (GH) and Day One Biopharmaceuticals (DAWN)

TipRanksNov 7, 2023 07:50 ET

Needham Reiterates Buy on Day One Biopharmaceutical, Maintains $34 Price Target

BenzingaNov 7, 2023 06:55 ET

Day One Biopharmaceutical Analyst Ratings

BenzingaNov 7, 2023 06:54 ET

High Approval Chances and Promising Safety Profile Boost Day One Biopharmaceuticals' Stock: A Buy Rating Recommendation

TipRanksNov 7, 2023 06:31 ET

Sell Rating on Day One Biopharmaceuticals: An Analysis of FDA Approval Uncertainties and Regulatory Concerns

TipRanksOct 31, 2023 05:18 ET

Positive FDA Reception and Compelling Data Boost Confidence in Day One Biopharmaceuticals: A Buy Recommendation

TipRanksOct 30, 2023 11:26 ET